Biology of advanced uveal melanoma and next steps for clinical therapeutics.
Biology of advanced uveal melanoma and next steps for clinical therapeutics.
复制标题
DOI:
10.1111/pcmr.12304
复制
发表时间:
2015-03
影响因子:
4.3
通讯作者:
Carvajal RD
中科院分区:
文献类型:
--
作者:
Luke JJ;Triozzi PL;McKenna KC;Van Meir EG;Gershenwald JE;Bastian BC;Gutkind JS;Bowcock AM;Streicher HZ;Patel PM;Sato T;Sossman JA;Sznol M;Welch J;Thurin M;Selig S;Flaherty KT;Carvajal RD
Uveal melanoma is the most common intraocular malignancy though it is a rare subset of all melanomas. Uveal melanoma has distinct biology relative to cutaneous melanoma, with widely divergent patient outcomes. Patients diagnosed with a primary uveal melanoma can be stratified for risk of metastasis by cytogenetics or gene expression profiling, with approximately half of patients developing metastatic disease, predominately hepatic in location, over a 15 year period. Historically, no systemic therapy has been associated with a clear clinical benefit for patients with advanced disease and median survival remains poor. Here, as a joint effort between CURE OM and the National Cancer Institute, the current understanding of the molecular and immunobiology of uveal melanoma is reviewed, and on-going laboratory research into the disease is highlighted. Finally, recent investigations relevant to clinical management via targeted and immunotherpies are reviewed and next steps in the development of clinical therapeutics are discussed.
登录
查看更多内容
影响因子:
11.2
作者:
Hallermalm, K;De Geer, A;Levitskaya, J
通讯作者:
Levitskaya, J
影响因子:
--
作者:
Dithmar, S;Rusciano, D;Grossniklaus, HE
通讯作者:
Grossniklaus, HE
影响因子:
15.9
作者:
Eyles, Jo;Puaux, Anne-Laure;Abastado, Jean-Pierre
通讯作者:
Abastado, Jean-Pierre
影响因子:
3.4
作者:
Chen, Peter W.;Mellon, Jessamee K.;Niederkorn, Jerry Y.
通讯作者:
Niederkorn, Jerry Y.
影响因子:
3.6
作者:
Achberger S;Aldrich W;Tubbs R;Crabb JW;Singh AD;Triozzi PL
通讯作者:
Triozzi PL